Tenosynovial Giant Cell Tumours: A Clinicopathologic Study of a Case-Series.

Sage open pathology Pub Date : 2025-05-30 eCollection Date: 2025-01-01 DOI:10.1177/30502098251341137

Toukilnan Djiwa, Mayi Bombone, Bagassam Sama, Panakinao Simgban, T H Towoezim, Tchin Darré

{"title":"Tenosynovial Giant Cell Tumours: A Clinicopathologic Study of a Case-Series.","authors":"Toukilnan Djiwa, Mayi Bombone, Bagassam Sama, Panakinao Simgban, T H Towoezim, Tchin Darré","doi":"10.1177/30502098251341137","DOIUrl":null,"url":null,"abstract":"Introduction: Tenosynovial giant cell tumours (TSGCT) are rare mesenchymal tumours that develop in joints, bursae and tendon sheaths. The aim of this study was to describe the epidemiological, clinical and histopathological aspects of this pathology in Togo.Methodology: This was a retrospective descriptive and analytical study of histologically confirmed cases of tenosynovial giant cell tumour from 1 January 2014 to 31 December 2023 in the Pathology Department of the Sylvanus Olympio Teaching Hospital in Lomé, Togo.Results: We identified 12 cases of tenosynovial giant cell tumours. We found 8 male subjects and 4 female subjects. The mean age of our patients was 24.2 ± 12.8 years. The tumour was located in the fingers in 9 cases (75%) and in the toes in 3 cases (25%). The mean time to diagnosis was 26.3 + 20.8 months. Pain and a palpable mass were the main symptoms. The nodular type was found in 7 cases (58.33%) and the diffuse type in 5 cases (41.67%).Conclusion: Tenosynovial giant cell tumour is a benign proliferative disorder of the synovium, the aetiopathogenesis of which remains undetermined.","PeriodicalId":520893,"journal":{"name":"Sage open pathology","volume":"18 ","pages":"30502098251341137"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12161886/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sage open pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/30502098251341137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Tenosynovial giant cell tumours (TSGCT) are rare mesenchymal tumours that develop in joints, bursae and tendon sheaths. The aim of this study was to describe the epidemiological, clinical and histopathological aspects of this pathology in Togo.

Methodology: This was a retrospective descriptive and analytical study of histologically confirmed cases of tenosynovial giant cell tumour from 1 January 2014 to 31 December 2023 in the Pathology Department of the Sylvanus Olympio Teaching Hospital in Lomé, Togo.

Results: We identified 12 cases of tenosynovial giant cell tumours. We found 8 male subjects and 4 female subjects. The mean age of our patients was 24.2 ± 12.8 years. The tumour was located in the fingers in 9 cases (75%) and in the toes in 3 cases (25%). The mean time to diagnosis was 26.3 + 20.8 months. Pain and a palpable mass were the main symptoms. The nodular type was found in 7 cases (58.33%) and the diffuse type in 5 cases (41.67%).

Conclusion: Tenosynovial giant cell tumour is a benign proliferative disorder of the synovium, the aetiopathogenesis of which remains undetermined.

查看原文本刊更多论文

腱鞘巨细胞瘤：一个病例系列的临床病理研究。

简介：腱鞘巨细胞瘤（TSGCT）是发生在关节、滑囊和肌腱鞘的罕见间充质肿瘤。本研究的目的是描述多哥这种病理的流行病学、临床和组织病理学方面。方法：本研究是对2014年1月1日至2023年12月31日在多哥洛莫雷市希尔瓦努斯奥林匹奥教学医院病理部病理确诊的腱鞘巨细胞瘤病例进行回顾性、描述性和分析性研究。结果：我们发现了12例腱鞘巨细胞瘤。我们找到8名男性受试者和4名女性受试者。患者平均年龄24.2±12.8岁。肿瘤位于手指9例（75%），脚趾3例（25%）。平均诊断时间为26.3 + 20.8个月。疼痛和可触及的肿块是主要症状。结节型7例（58.33%），弥漫性5例（41.67%）。结论：腱鞘巨细胞瘤是一种良性滑膜增生性疾病，其发病机制尚不明确。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Sage open pathology

自引率

0.00%

发文量